LAWRENCE, Mass., Aug. 24, 2017 /PRNewswire/ -- NxStage Medical, Inc. (Nasdaq: NXTM), a leading medical technology company focused on advancing renal care, today announced that the NxStage® System One™ ...

LAWRENCE, Mass., Oct. 18, 2018 /PRNewswire/ -- NxStage Medical, Inc. (Nasdaq: NXTM), a leading medical technology company focused on advancing renal care, announced new findings demonstrating ...

LAWRENCE, Mass., Jan. 13, 2016 /PRNewswire/ -- To coincide with the sixth anniversary of the 2010 Haiti earthquake, NxStage Medical, Inc. (Nasdaq: NXTM), a leading manufacturer of dialysis products, ...

NxStage Medical, a medical technology outfit focused on advancing renal care, has received clearance from the FDA for its System One, which allows for solo home hemodialysis, without a care partner, ...

The home-dialysis market is a growing one because of the rise in incidence of diabetes and other diseases that can have an impact on kidney function. NxStage Medical (NASDAQ: NXTM) has done its best ...

NxStage Medical Inc. and Spindial S.p.A., a distributor of renal care products in Italy, announced a partnership with the Niguarda-Ca’ Granda hospital in Milan assist hemodialysis patients. The ...

NxStage (NXTM) - Get Free Report surged 35% after signing a home dialysis partnership with DaVita (DVA) - Get Free Report. DaVita said it bought $20 million in NxStage stock, giving it a 7% stake.

Medical device firm NxStage Medical Inc. says that it has raised $43 million through private placement of its common stock and warrants. Officials at Lawrence-based NxStage (Nasdaq: NXTM) said the ...

Feb 8 (Reuters) - Shares of medical equipment maker NxStage Medical Inc. topped the Nasdaq gainers list on Thursday, surging almost 50 percent, a day after news that DaVita Inc. has acquired about 7 ...